Abstract
In 2002, human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 seroprevalence was 0.16% (8/4,900) in blood donors from Dakar, Senegal. Most of the positive donors originated from the country's southern region. Seven donors were infected by HTLV-1 (of cosmopolitan subtype), and one was infected by HTLV-2. These data highlight the problem of transfusion safety in this area where HTLV-1-associated lymphoproliferative and neurological diseases are endemic.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Blood Donors
-
HTLV-I Antibodies / analysis
-
HTLV-I Antigens / analysis
-
HTLV-I Antigens / immunology
-
HTLV-I Infections / epidemiology*
-
HTLV-I Infections / immunology
-
HTLV-I Infections / virology
-
HTLV-II Antibodies / analysis
-
HTLV-II Antigens / analysis
-
HTLV-II Antigens / immunology
-
HTLV-II Infections / epidemiology*
-
HTLV-II Infections / immunology
-
HTLV-II Infections / virology
-
Human T-lymphotropic virus 1 / genetics*
-
Human T-lymphotropic virus 1 / isolation & purification
-
Human T-lymphotropic virus 2 / genetics*
-
Human T-lymphotropic virus 2 / isolation & purification
-
Humans
-
Molecular Epidemiology*
-
Molecular Sequence Data
-
Phylogeny
-
Prospective Studies
-
Senegal / epidemiology
-
Seroepidemiologic Studies*
Substances
-
HTLV-I Antibodies
-
HTLV-I Antigens
-
HTLV-II Antibodies
-
HTLV-II Antigens
Associated data
-
GENBANK/DQ235698
-
GENBANK/DQ235699
-
GENBANK/DQ235700
-
GENBANK/DQ235701
-
GENBANK/DQ235702
-
GENBANK/DQ235703
-
GENBANK/DQ235704
-
GENBANK/DQ235705
-
GENBANK/DQ235706